ResMed Inc. (RMD) Social Stream



ResMed Inc. (RMD): $205.31

0.48 (+0.23%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

B

RESMED INC (RMD) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering RMD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-01 12 $312 $227 $261.5 $173 51.16%
2021-12-21 11 $312 $227 $264.875 $173 53.11%
2022-01-13 11 $312 $234 $273.25 $173 57.95%
2022-01-18 11 $312 $234 $272.125 $173 57.3%
2022-01-24 11 $312 $234 $273.5 $173 58.09%
2022-01-25 11 $312 $234 $274.75 $173 58.82%
2022-01-28 11 $312 $235 $272.125 $173 57.3%
2022-03-24 11 $312 $235 $272.75 $173 57.66%
2022-04-06 11 $312 $235 $273.555 $173 58.12%
2022-04-26 11 $312 $235 $273 $173 57.8%
2022-05-01 11 $312 $201 $264.666 $173 52.99%
2022-05-02 11 $300 $201 $257.777 $173 49%
2022-05-27 12 $300 $201 $257.777 $173 49%
2022-06-06 12 $300 $201 $259.777 $173 50.16%
2022-06-14 12 $300 $201 $258.111 $173 49.2%
2022-06-16 12 $300 $201 $254.875 $173 47.33%
2022-07-24 11 $300 $204 $259 $173 49.71%
2022-08-12 11 $300 $204 $259 $173 49.71%
2022-08-13 11 $300 $222 $263.125 $173 52.1%
2022-08-16 11 $300 $222 $262.5 $173 51.73%
2022-10-05 11 $300 $222 $262.5 $173 51.73%
2022-10-12 12 $300 $222 $260.555 $173 50.61%
2022-10-26 12 $300 $222 $262.222 $173 51.57%
2022-10-28 12 $300 $222 $262.222 $173 51.57%
2022-12-01 12 $300 $211 $261.111 $173 50.93%
2022-12-13 11 $300 $211 $261.111 $173 50.93%
2023-01-12 10 $280 $211 $256.25 $173 48.12%
2023-01-27 9 $280 $219 $256.857 $173 48.47%
2023-04-18 10 $280 $219 $256.875 $173 48.48%
2023-04-28 10 $280 $219 $257.062 $173 48.59%
2023-05-03 10 $280 $229 $258.125 $173 49.21%
2023-05-22 11 $290 $229 $261.666 $173 51.25%
2023-08-04 11 $290 $207 $254.555 $173 47.14%
2023-08-07 11 $290 $207 $257.888 $173 49.07%
2023-08-14 11 $290 $207 $251.111 $173 45.15%
2023-09-06 12 $275 $170 $234.777 $173 35.71%
2023-09-13 11 $275 $170 $217.555 $173 25.75%
2023-09-18 11 $275 $170 $215.333 $173 24.47%
2023-10-05 12 $275 $165 $207 $173 19.65%
2023-10-12 12 $275 $165 $199.111 $173 15.09%
2023-10-16 12 $220 $165 $186.888 $173 8.03%
2023-10-20 12 $220 $165 $182.444 $173 5.46%
2023-10-27 12 $220 $165 $182.444 $173 5.46%
2023-10-29 12 $220 $158 $180.444 $173 4.3%
2023-10-30 12 $220 $158 $178.222 $173 3.02%
2023-10-31 12 $220 $158 $177.111 $173 2.38%
2023-12-07 13 $220 $155 $176.777 $173 2.18%
2023-12-21 13 $220 $155 $179 $173 3.47%

The Trend in the Analyst Price Target


Over the past 30 months, RMD's average price target has gone down $49.33.

Over the past 49 weeks, RMD's average upside potential has been 26.89%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-27 8 280 219 256.857 224.59 14.37%
2023-05-03 10 280 229 258.125 236.80 9.01%
2023-07-05 11 290 221 260.777 216.44 20.48%
2023-07-17 11 290 221 260.777 220.77 18.12%
2023-09-06 12 275 170 234.777 153.33 53.12%

RMD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.73 7 2 4 0 0 13

The Trend in the Broker Recommendations


Over the past 19 months, RMD's average broker recommendation rating worsened by 0.1.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • RESMED INC's average analyst price target is greater than 5786.67% of all US stocks.
  • In terms of how RESMED INC fares relative to stocks in the large market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 4701.54% of that group.
  • RMD has a lower variance in analysts' estimates than -1560.38% of Healthcare stocks.
  • RMD has a higher number of analysts covering the stock than 4446.75% of Healthcare stocks.

Stocks similar to RESMED INC in the Medical Equipment industry regarding analyst recommendations and price targets are TFX, XRAY, and ALC.

Make investment decisions regarding RMD using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!